Be in the know. 20 key reads for Saturday…

  1. Opinion: Seven reasons the beleaguered biotech sector is now a ‘buy’ (marketwatch)
  2. Seagen’s stock surges after WSJ reports $31 billion-valued biotech is being eyed by Merck (marketwatch)
  3. China’s Stocks Are Bucking Global Market Volatility. Tech Is Leading the Way. (barrons)
  4. Buffett’s Last Lunch Auction Draws Record $19 Million Bid (bloomberg)
  5. Inside IBD 50: Once-Robust Oil Stocks Fading Fast, Some Hit Sell Signals (investors)
  6. New York Fed Model Sees High Probability of Hard Landing for Economy (wsj)
  7. Self-Driving Big Rigs Are Coming. Is America Ready? (wsj)
  8. Retailers’ Inventories Pile Up as Lead Times Grow (wsj)
  9. YouTube Shorts Is Huge In India, Now It’s Going After TikTok in U.S. (wsj)
  10. US Open heading into epic weekend with stars atop leaderboard (nypost)
  11. Citigroup Stock Is the Cheapest of the Big Banks. It’s Ready to Take Off. (barrons)
  12. The Days of Big Pharma Are Over. What the Era of Big Biotech Means for Investors. (barrons)
  13. Markets Won’t Sink Forever. Asset Manager Stocks Are a Cheap Play on a Recovery. (barrons)
  14. Why stock-market investors are ‘nervous’ that an earnings recession may be looming (marketwatch)
  15. History says the next bull market is just months away, and it could carry the S&P 500 to the 6,000 level, according to Bank of America (marketwatch)
  16. Mereo BioPharm and Theseus Pharmaceuticals See Action From Activist Investors (barrons)
  17. Fed Rate Hikes Will End Sooner Than You Think. What That Means for the Stock Market. (barrons)
  18. Bitcoin sinks below $20,000 as crypto meltdown intensifies (cnbc)
  19. Is the Avalanche’s Defenseman the Stephen Curry of Hockey? (nytimes)
  20. Retail Traders Who Drove Meme Frenzy Bail Out in Bear Market (bloomberg)